Bio-Rad Laboratories' BioPlex 2200 ToRC IgM Assay has been granted clearance by the FDA. The automated and multiplexed panel, which complements the company's BioPlex 2200 ToRC IgG Assay, is designed for detecting IgM class antibodies to congenital disease-associated pathogens, including Toxoplasma gondii, rubella and cytomegalovirus.
Congenital disease IgM assay from Bio-Rad gets FDA clearance
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.